BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 984732)

  • 1. [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].
    de Mouzon A; Ohayon E; Oksman-Domejean F; Ducos J
    Ann Immunol (Paris); 1976; 127(5):687-701. PubMed ID: 984732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practical interest of a micromethod for neuraminidase treatment of lymphocytes in transplantation immunology (author's transl)].
    de Mouzon A; Ohayon E; Durand D; Ducos J
    Pathol Biol (Paris); 1976 Dec; 24(10):685-9. PubMed ID: 796790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.
    Bray J; Lemieux RU; McPherson TA
    J Immunol; 1981 May; 126(5):1966-9. PubMed ID: 7217675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-specific human alloantisera to antigens segregating outside the major histocompatibility complex.
    Schacter B; Pollard K; Maylock R; Humphrey RL; Hsu SH; Bias WB
    Transplant Proc; 1977 Mar; 9(1):635-7. PubMed ID: 301310
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.
    Sadeghee S; Hebert J; Kelley J; Abdou NI
    J Immunol; 1975 Sep; 115(3):811-6. PubMed ID: 125303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of kidney cells with cytotoxic antisera: possible evidence of kidney-specific antigens.
    Perkins HA; Gantan Z; Siegel S; Howell E; Belzer FO; Kountz SL
    Tissue Antigens; 1975 Apr; 5(2):89-98. PubMed ID: 1093285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the foeto-maternal immunization using the LDA test (author's translation)].
    Levy S; Tongio MM; Mayer S
    Nouv Rev Fr Hematol (1978); 1976; 16(3):337-44. PubMed ID: 64966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional correlation between antibody-dependent and spontaneous cytotoxic activity of human lymphocytes and possibility of an HLA-related control.
    Trinchieri G; Santoli D; Zmijewski CM; Koprowski H
    Transplant Proc; 1977 Mar; 9(1):881-4. PubMed ID: 867507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Materno-foetal transfer of anti-HLA antibodies. Study by using LDA test (author's transl)].
    Lévy S; Tongio MM; Mayer S
    Nouv Rev Fr Hematol (1978); 1978; 20(4):605-10. PubMed ID: 377226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.
    Ferrone S; Ting A; Pellegrino MA; Terasaki PI; Reisfeld RA
    J Clin Invest; 1975 Feb; 55(2):388-94. PubMed ID: 1092715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.
    Ray PK; Sundaram K
    Clin Exp Immunol; 1975 Mar; 19(3):529-32. PubMed ID: 1204249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the antibody-dependent lymphocytotoxicity test as a function of the nature of the antibodies].
    Levy S; Tongio MM; Mayer S
    Pathol Biol (Paris); 1977 Mar; 25(3):175-7. PubMed ID: 323786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane expression of Thy-1,2 and GM1 ganglioside on differentiating T lymphocytes.
    Milewicz C; Miller HC; Esselman WJ
    J Immunol; 1976 Nov; 117(5 Pt.2):1774-80. PubMed ID: 1086862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans.
    Santoli D; Trinchieri G; Zmijewski CM; Koprowski H
    J Immunol; 1976 Sep; 117(3):765-70. PubMed ID: 956652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes.
    Rojo S; López de Castro JA; Aparicio P; Van Seventer G; Bragado R
    J Immunol; 1986 Aug; 137(3):904-10. PubMed ID: 2424988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.